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The transient manifold structure of the p53
extreme C-terminal domain: insight into disorder,
recognition, and binding promiscuity by
molecular dynamics simulations†
E. Fadda * and M. G. Nixon
The p53 tumour suppressor is a transcription activator that signals for cell cycle arrest and apoptosis. In
its active form p53 is a tetramer, with each monomer organised in domains with different degrees of
structural stability, ranging from the well folded DNA-binding domain (DBD) and tetramerization domain
(TET), to the intrinsically disordered transactivation domain (TAD), and extreme C-terminal domain
(CTD). Compared to all other domains, the structure/function relationship of the p53-CTD within the
full-length p53 tetramer is still poorly understood due to its high degree of conformational disorder.
Meanwhile, the structure of p53-CTD-like peptides has been well characterized when in complex with a
variety of receptors, where, as other intrinsically disordered regions (IDR), it adopts specific, while
diverse, conformations. Receptor-specific folding is likely to occur upon binding, either from a random
coil, or as a result of an initial recognition of a pre-formed structural motif, known as molecular
recognition feature (MoRF), selected by the receptor within the conformational ensemble of the IDP in
solution. In this latter case, MoRFs act as nucleation sites, favouring the initiation of the folding process
within the binding site. In this work we show the results of over 20 ms of cumulative molecular dynamics
(MD) simulations of a 22 residue peptide unbound in solution with sequence corresponding to the
p53-CTD 367–388 section. Such extensive sampling allowed us to identify and characterize the structure
of specific sets of minimal structural MoRFs within the p53-CTD peptide conformational ensemble at
equilibrium. These motifs are short, involving only 3 to 4 residues, and specifically localized within the
peptide sequence. Corresponding patterns of secondary structure propensity along the p53-CTD
sequence are also predicted by disorder prediction calculations. Based on these findings we discuss how
the structural complementarity of specific minimal structural MoRFs to the binding site of different
receptors could regulate the p53-CTD binding promiscuity.
Introduction
Conformational disorder is a common trait in a large part of
proteins encoded in the human genome.1–3 In contrast with the
classic ‘structure-function’ relationship view, according to which
protein function is inextricably related to a specific and stable
native structure, the functional role of protein disorder is
manifold,4–6 crucial in regulatory and signalling pathways,1,3,7
as well as conferring key mechanical properties to proteins.8,9
The interaction between structured and intrinsically disordered
regions (IDR) seems to follow also different principles relative to
the formation of obligate protein–protein complexes.5,7,10 Indeed, in
obligate complexes the counterparts have highly complementary
and preformed contact areas,11,12 and only minor conformational
changes occur upon binding.13 IDR are not only structureless in
solution, but often display broad specificity towards a set of different
receptors.1,7 Moreover, their bound conformation can vary widely in
function of the specific receptor they are in complex with.2,5,11,14,15
Contact areas between IDR and their receptors are generally small,16
contributing to lower the binding affinity, thus favouring transient
and reversible binding.15–17 One prime example of this behaviour is
given by the p53 extreme C terminal domain (CTD), a 30 residue
highly basic IDR of the p53 tumour suppressor. The p53-CTD
has been shown to have a negative regulatory control of the p53
DNA-binding activity,18–20 with phosphorylation or deletion of
the p53-CTD region resulting in a constitutively DNA-binding
active p53 molecule.21 The p53-CTD is also highly targeted for
post-translational modifications, which modulate its DNA-binding
activity.21,22 The p53-CTD is poorly structured in solution,23,24 but
it adopts a variety of stable secondary structures when bound
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to different receptors, ranging from a helices, to coils.14,23,25
Recognition and binding could follow these different mechanistic
scenarios, (a) a non-specific ‘‘encounter complex’’ is initially
formed between peptide and receptor, followed by an induced
fit phase, where the progressive setting of specific interactions
drives folding, or (b) the peptide unbound in solution can access
its bound fold, which is selected and bound by the target
receptor, i.e. by conformational selection, or (c) a mechanism
in between these two scenarios, whereby conformational selection
and induced fit both play a role.26,27 In the specific case of the
p53-CTD, it has been determined that the folded conformations
are stable only when the peptide is bound.23,28,29 Intricate balances
regulating recognition and binding are not unusual for
IDPs.23,28–35 Because of the high degree of intrinsic disorder,
structural investigations of the unbound p53-CTD in solution
have not been particularly informative in terms of subtleties in
its residual secondary structure.19 Nevertheless, this does not
necessarily mean that there isn’t any residual secondary structure.
Indeed, single molecule fluorescence experiments have shown that
peptides previously characterized as completely disordered by
ensemble approaches, do stochastically switch between subsets
of conformations.36 As a specific class of single molecule
experiments, molecular simulation methods have been shown
high potential in describing the structure, dynamics, and energetics
of structural disorder at the atomistic level of detail33,37–40 and
results of such studies can provide important information that
can be used to guide targeted experiments.
Recent work strongly suggests that recognition and binding
mechanisms of IDPs depends on their intrinsic secondary
structure propensity, dictated by the peptide/protein sequence.34
In this work we used extensive molecular dynamics (MD)
simulations to analyse at the atomistic level of detail the
conformational propensity of the unbound p53-CTD in solution
and to investigate the structure and potential roles of transi-
ently stable structural motifs in recognition and binding.41
Indeed, these motifs could function as molecular recognition
features (MoRFs),7,42 by being selectively targeted by different
receptors, thus working as nucleation sites for the completion
of the folding by induced fit.1,3,4,41 Also, an intrinsic propensity
to form minimal structural motifs that can be specifically
recognized by different receptors would explain how the p53-
CTD conformational disorder supports its binding promiscuity.43
The analysis of over 20 ms of cumulative MD simulation
trajectories of a 22 residue peptide free in solution, with sequence
corresponding to the p53-CTD 367SHLKSKKGQSTSRHKKLMFKTE388
segment, suggest that the p53-CTD conformational disorder
includes in addition to random coils, also structures containing
specific, relatively stable, localized and reoccurring short secondary
structure motifs, which encompass stretches of 3 to 4 residues in
case of helical turns. The results also show that the MoRFs we
identified occur with higher probability in the C-terminal half of
the peptide, while the N-terminal half remains mostly disordered.
These findings are in agreement with structure/disorder prediction
tools, namely s2D44 and PONDR-VL-XT45 that show a different
degree of structural propensity along the p53-CTD sequence.
The identification of such distinct motifs within the disordered
ensemble suggests that the p53-CTD may exert its broad binding
specificity throughminimal structural MoRFs, which are specifically
selected and bound by different receptors, fitting within a broader
framework of the conformational selection theory.26,27 We discuss a
potential MoRF-based recognition and binding mechanism in the
case of the p53-CTD peptide in complex with the Ca2+ bound
S100B(bb) dimer,23 and with sirtuin Sir2.25
Computational method
A 22 residue peptide corresponding to the 367–388 aa section of
the H. sapiens p53-CTD was built in a fully extended conformation
with the molecular builder tool in Maestro v.9.7.46 N- and
C-termini were capped with ACE and NME residues, respectively.
The fully extended peptide, measuring 8.4 nm, was centred in
a truncated dodecahedral simulation box sized so that the
minimum distance between the peptide and the box sides
would not be lower than 1.2 nm. The total charge of +6 was
neutralized with the addition of Cl counterions. Because the
aim of this work is to determine the conformational propensity
of the peptide in function of its sequence, the effect of ionic
strength in physiological conditions has not been addressed.
Protein atoms and counterions were represented with AMBER-
99SB-ILDN parameters,47 while TIP4P-Ew48 was chosen as water
model. Because the choice of force field parameters can greatly
affect the reliability of the simulations, the search for an
optimal force-field selection for poorly structured and unstructured
proteins is a topic very much under scrutiny nowadays.37,38,49–53 The
large number of existing protein/solvent parameters combinations
and the complex behaviour of proteins in terms of their intrinsic
structural propensity or lack-there of, makes the designation of
an absolute best choice quite difficult.37,38,51–54 Our selection of
parameters was based on the proven reliability and robustness
of the AMBER-99SB-ILDN/TIP4P-Ew force field in the simulation
of structured proteins,37,52 in view of its satisfactory performance
in the prediction of residual secondary structure in disordered
peptides.38 It should be noted that AMBER-99SB-ILDN, when in
combination with TIP3P, has been shown to underestimate chain
dimensions37,38 and has shown slower dynamics relative to other
force fields combinations.51 Convergence of our simulations has
been verified by monitoring, (a) the average backbone RMSD
values, calculated relative to 2 distinct and highly populated
MoRFs we identified, namely an asymmetric b sheet hairpin
(cluster 1, MD1) and a conformer containing a 310 helical turn
located at 376STS378 (cluster 2, MD3), and (b) the corresponding
backbone RMSD running averages, and (c) the RMSD average
correlation values (RAC).55 These data sets are included as
Supplementary Material and shown in Fig. S1 (ESI†), panels
(a)–(c), respectively.
Bond lengths with hydrogen atoms were constrained with
the LINear Constraint Solver (LINCS) algorithm. Long range
electrostatic interactions were treated with Particle Mesh Ewald
(PME), with a 1.2 nm cutoff. van der Waals interactions were
also cutoff at 1.2 nm. All MD simulations were run with version
4.6.3 of GROMACS.56 Two additional simulations, each of 2 ms
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production, were run starting with the p53-CTD peptide in the
helical conformation seen when in complex with S100B(bb)
(PDBid 1dt7). The following protocol was used to set-up and
run all simulations in this work. An initial energy minimization
of 500 k steps of steepest descent were used to prepare the
system for the equilibration phase. During the minimization
only the positions of the solvent molecules, counterions, and
hydrogen atoms was left unconstrained. 500 ps of equilibration
in the NVT ensemble and subsequently 500 ps in the NPT
ensemble followed, with a target temperature of 300 K and
pressure of 1 bar. Following this stage, a 1 ns equilibration was
run with the backbone atoms restrained (C–N–Ca) and the
sidechain atoms free. All restraints were then released for 5 ns
and a 100 ns production run was recorded for analysis. From
this trajectory, snapshots were collected every 10 ns. The
10 uncorrelated peptide structures were removed from their
original simulation box and placed in a truncated dodecahedral
simulation box of 8.4 nm sides, sized to leave enough space to
accommodate largely extended conformations that may occur
during the simulation. The minimization and equilibration
protocol described above was repeated for all 10 systems.
Production of every trajectory was extended to 2 ms, for a total
simulation time of 20 ms. The choice of running a series of
independent MD simulations instead of enhanced sampling
schemes was based on the fact that we wanted to monitor the
dynamic interconversion of MoRFs with the aim of identifying
an interconversion coordinate, if possible. The clustering analysis
was performed with the gromos algorithm57 implemented in the
g_cluster tool in GROMACS, with a cutoff of 0.45 nm. Such large
cutoff value is necessary due to the highly dynamic nature of the
N-terminal tail of the peptide, and it was found as the minimum
cutoff value that allows us to separate and group significant
secondary structure motifs. The secondary structure analysis was
done on the 10 highest populated clusters obtained from each
MD trajectory. These clusters are representative of a minimum of
63% of all conformations accessible, in case of high conforma-
tional dynamics, up to a complete coverage of 100%, in case of
the formation of stable secondary structure motifs. MoRF popu-
lations for each MD trajectory were calculated based on clusters
populations, with counts of 1 ns per frame. Populations over
the cumulative 20 ms simulation were estimated as sums of the
populations during the single trajectories, where the error bars
corresponds to the standard deviation. Secondary structures
were assigned according to the STRIDE online tool.58 Image
rendering, structural alignments, and distance analysis was
done with PyMOL v.1.6.
Results
The conformational dynamics of a 22 residue peptide, corres-
ponding to the Ser 367 to Glu 388 section of the p53-CTD, was
analyzed with molecular dynamics (MD) for a cumulative time
of 20 ms. The simulation is an aggregate of 10 separate trajectories,
started from uncorrelated snapshots, selected from a 100 ns
trajectory started from a fully extended backbone conformation.
In addition to these 10 separate trajectories, we ran 2 separate, 2 ms
long, trajectories, both started from the helical conformation of
p53-CDT peptide when in complex with S100B(bb)23 (PDBid 1dt7).
These calculations were run to assess the stability of the helix in
solution and the residual helicity retained in function of the
starting structure.
The p53-CTD peptide size was analysed in terms of its radius
of gyration (Rg). The average Rg calculated over the combined
20 ms trajectories is 0.97 0.07 nm. This value is larger than the
Rg value 0.73 nm, predicted for a 22 residue random-flight
polymer with link distances of 0.38 nm, representative of a
random coil behaviour, but smaller than 1.01  0.04 nm, the Rg
measured for the Ace-(AAKAA)4-GY-NH2 peptide, containing
well structured a helical motifs.59 It should be noted that the
Amber-99SB-ILDN has been shown to produce an overall more
compact ensemble relative to experiment.37,38 The Rg plots
obtained from the 10, 2 ms long, trajectories are shown in
Fig. S3 (ESI†). The trends describe a highly dynamic structure
with recurrent signatures of relatively stable conformers. These
correspond to localized and short secondary structure motifs,
which we have classified through clustering analysis and are
described in the sections below. The relative populations of
the secondary structure motifs identified over the 20 ms of
cumulative simulation time are shown in Fig. 1 and in Table 1.
The highest populated structures contain b-bridges (27.3%),
and b-sheet hairpins (25.7%). We also identified helical turns
(13%), both a-helical, and 310. Random coils and turns, which
contribute the most to the disordered character of the peptide,
have a relative population of 15.2%. Interestingly, similar secondary
structure motifs form recurrently throughout the dynamics, and are
found to involve preferentially the same group of residues within
the C-terminal half of the peptide.
b-Sheet hairpin motifs
As shown in the Rg plot in Fig. S3 (ESI†), the first MD trajectory
(MD1) visits a relatively stable conformation between 400 ns
and 1.5 ms. In this interval the peptide is in an asymmetric
b-sheet conformation, shown in Fig. 2. The core of the b-sheet
is held together by hydrogen bonds connecting Ser 376 and Phe
385, while the free N-terminal tail, spanning residues Ser 367 to
Gly 374 (367SHLKSKKG374), is not tied into the hairpin and its
dynamics determines the oscillations of the Rg value. The
hairpin turn comprises His 380 and Lys 381. This conformation
is the highest populated, stable for 55% of the simulation time,
or more than half of the MD1 trajectory. The structural alignment
of all the b-sheet motifs found during all the other simulations
shows that this particular asymmetric hairpin conformation is
the highest populated type of b-sheet, also present in MD6 with
63.4% population over 2 ms, MD7 with 17.7% population, MD8
with 89.0% population, and MD10 with population of 23.0%.
Two other slightly different, and lower populated, b-sheet con-
formations have been identified, one in MD5, with a population
of 3.8% over 2 ms, and the other in MD10, with a population of
4.4%. As shown in Fig. S3 in ESI,† these two conformers show the
same asymmetry, but one (MD10) has a wider hairpin section,
formed by Lys 381, Lys 382, and Leu 383, and the other one
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(MD5) with a slightly different hydrogen bonding pattern relative
to the highest populated motif, connecting not only Ser 376 to
Phe 385, but also Ser 378 to Met 386. An RMSD matrix obtained
through sequence alignment of the 15 residues stretch between
Gly 375 and Glu 388, followed by structural alignment of all the
b-sheet motifs, is shown in Table S2 in the ESI.†
b-Bridges containing motifs
As shown in Fig. 1, structures containing b-bridges are the
highest populated over the 20 ms MD. Because of the degree of
conformational flexibility a single hydrogen bond allows, structures
containing b-bridges can be quite different, ranging from elongated
narrow hairpins, to globular folds containing one or two b-turns, see
Fig. S5 (ESI†). The most stable hairpins that contain b-bridges are
structurally similar to asymmetric hairpins described in the previous
section. In fact, these b-bridge hairpins also present along dynamic
tail that comprises residues Ser 367 to Gly 374 (367SHLKSKKG374)
and also have His 380 and Lys 381 at the hairpin turn. The largest
group of stable, narrow, asymmetric hairpins was visited during
MD7 with 76.7% population over 2 ms MD, see Fig. S4 (ESI†). The
structure of the highest populated hairpins containing b-bridges
and b-sheet hairpins are structurally very similar; they fall in
different categories as the MoRFs structure classification we
used is based on the STRIDE definition of the clusters middle
structure. Indeed, clusters of narrow hairpins with a b-bridge
often also contain b-sheets and vice versa.
310 and a helical turns
Over the 20 ms MD we were able to distinguish 3 significantly
populated short helical motifs, either 310 or a single helical
turns. Representative structures are shown in Fig. 3. The highest
populated helical MoRF involves a 3 residue segment, between
Table 1 Relative populations (%) of the secondary structure motifs
identified during each trajectory. MD 1–10 are trajectories started from a
common fully extended peptide, see Computational method section,
while Helix 1–2 MD indicate trajectories started from the a helical
conformation from the complex with S100B(bb) (PDBid 1dt7). Populations
are calculated over 2 ms and account for the 10 highest populated clusters.
The total reflects the populations over 20 ms cumulative sampling, where
the standard deviation is indicated in brackets
Trajectory b-Strands a/310 helices b-Bridges Coil/turns
MD 1 55.3 7.7 8.9 13.4
MD 2 0.0 19.1 0.0 53.4
MD 3 0.0 27.8 24.4 17.3
MD 4 0.0 0.0 81.4 14.5
MD 5 3.8 19.9 9.4 14.4
MD 6 63.4 7.1 26.5 4.7
MD 7 17.7 21.1 83.1 0.0
MD 8 89.0 0.0 8.9 2.2
MD 9 0.0 2.9 0.0 57.6
MD 10 27.5 24.8 30.1 6.0
Total (over 20 ls) 25.7(3.2) 13.0(1.1) 27.3(3.1) 18.3(2.0)
Helix 1 MD 0.0 52.7 0.0 30.7
Helix 2 MD 0.0 11.7 41.4 29.0
Fig. 2 Examples of the b-sheet motif identified through the clustering
analysis of the 20 ms MD simulation of the p53-CTD. The conformations
visited during MD 1, MD 7, and MD 8 (cluster 1 and 3), are shown in cyan,
red, green, and purple, respectively. The flexible tail corresponds to the
stretch between Ser 367 and Gly 374.
Fig. 1 Relative populations of secondary structure motifs identified over a cumulative 20 ms MD simulation of the 22 residue p53-CTD peptide.
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Ser 376 and Ser 378 (376STS378), with a relative population of
6.1% (0.3) over the cumulative 20 ms. Two helical motifs are
equally populated; one is located at the N-terminus end of the
peptide, stretching across Lys 370 to Lys 372 (370KSK372) with a
relative population of 2.4% (0.2) over 20 ms, and the other is
located at the C-terminus end, between Lys 381 and Leu 383
(381KKL383), with a relative population of 2.3% (0.8). Although
we found that the single helical turn motifs are in general less
stable overtime than the asymmetric b-sheet or b-bridge-containing
hairpins, we observed that the highest populated helical turns are
stable between 250 and 450 ns, see Fig. S6 (ESI†).
Stability of the S100B(bb)-bound conformation in solution
We ran 2 additional 2 ms trajectories to determine the stability
in solution of the a/310 helical structure of the 22 residue p53-
CTD peptide when in complex with the S100B(bb) dimer.23
According to the STRIDE classification, this structure is a
helical from Thr 377 to Met 384, and 310 helical from Phe 385
to Thr 387. As shown by the NMR ensemble23 (PDBid 1dt7),
large part of the N-terminal half of the peptide, i.e. from Ser 367
to Ser 376, is unbound and highly dynamic. Although the
helical structure of the peptide unfolds quite readily within the
first 2 ns of both trajectories, the secondary structure analysis in
Table 1 shows that a higher degree of helicity remains in one of
the two 2 ms trajectories, namely in Helix 1 MD, relative to all
other trajectories originated from the common fully extended
starting structure. A high degree of helicity in the unbound
p53-CTD was described in a recently published computational
work.60 Such strong conformational propensity is inconsistent
with circular dichroism data24,60 and could be due not only to
force field limitations, but also to the choice of starting structures
derived from the S100B(bb) bound conformation.60 In 30.7% of
the helical structures, the residual helicity spans the 381KKL383
stretch. In all other cases, single helical turns are observed in the
disordered, and unbound N-terminal tail, often in addition to
the helical turn at 381KKL383. As shown in Table 1, also during the
Helix 2 MD simulation, a residual helical character remains,
however much less predominant than in the case of Helix 1 MD.
Indeed, the highest populated cluster corresponds to an asymmetric
hairpin structure with a free N-terminal tail (Ser 367 to Lys 373),
similar to the b-bridge and b-sheet hairpin motifs observed during
the 20 ms simulationMD 1 to 10, described in the previous sections.
Average Rg values are 0.996 nm for Helix 2 MD and 1.059 nm for
Helix 1 MD, see Fig. S7 (ESI†).
Discussion
The extreme C-terminus of the p53 tumor suppressor (p53-CTD) is
a 30 residue long conformationally disordered,23 highly alkaline
region, responsible for regulating the p53 DNA binding activity.18–21
This intrinsically disordered region (IDR) is also highly targeted for
post-translational modifications, which modulate its DNA binding
activity.18,19,22,23,61 The p53-CTD binds numerous receptors,
adopting significantly different conformations when bound.14,23,25
In this work we used extensive sampling via MD simulations to
analyze the conformational propensity of a 22 residue peptide,
bearing all the binding determinants of the p53-CTD,23,62–64
while unbound in solution. Our objective was to characterize at
the atomistic level of detail the dynamic nature of the p53-CTD
peptide conformational ensemble at equilibrium and to search
for structural distinctive elements, or Molecular Recognition
Features (MoRFs), that could be specifically selected and bound
by different receptors, initiating receptor-specific folding patters.
As shown in Fig. 1, we have identified a set of distinct structural
MoRFs, significantly populated over 20 ms of cumulative sampling.
These include b-sheet and b-bridges-containing asymmetric
hairpins, conformations with 310 and a single helical turns, as
well as coils and turns-containing structures, which account for
the disordered nature of the peptide. An analysis of the size of
the peptide in terms of Rg values in relation to the relative
populations of the different structural MoRFs is shown in Fig. 4.
The most compact, and highest populated, conformations corre-
spond to asymmetric hairpin structures, examples of which are
shown in Fig. 2, while the most extended ones correspond to
disordered coils.
A comparison between the secondary structure propensity
per residue calculated over the 20 ms of MD simulation and
the disorder predictions obtained with the s2D44 and with the
PONDR-VL-XT45 tools is shown in Fig. 5. Provided that the
disorder scores obtained from the structure prediction tools are
Fig. 3 Short helical motifs identified during the 20 ms MD simulations. The labels indicate the group of residues where the helical turn is centred, and the
minimum stretch for a 310 turn, while the relative populations over 20 ms are indicated in brackets.
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not numerically comparable to the secondary structure propensity
values calculated from the MD simulations, or to each other, our
analysis shows a good agreement with the s2D data, which
predict a decrease in disorder (o70% disorder score) in the
377TSRHKKLMFKT387 segment, where we also observe the high-
est propensity for secondary structure. The PONDR-VL-XT
prediction is also in agreement with our data, showing a smoother
decrease in disorder from N- to C-terminus, with a significant
decrease for a slightly shorter sequence range relative to the s2D
data, namely 380HKKLMFKTE388. As shown in Fig. 5, the MD
data provide a rationalization for this decrease in disorder in the
C-terminal half of the peptide, by showing a higher propensity
for the formation of b-sheet asymmetric hairpins with a dis-
ordered N-terminal tail, and single helical turns. The propensity
to form short helical motifs is also detected in the mostly
disordered N-terminal half of the peptide, a trend mirrored by
a slight decrease in disorder predicted by the s2D tool, see
Fig. 5, panel (a).
The identification of these minimal structural motifs, or MoRFs,
provides a rationale that can explain the binding promiscuity of
p53-CTD, or its specificity towards multiple receptors. Our
working hypothesis is that the p53-CTD receptors have different
binding affinities for the structural MoRFs accessible at equilibrium,
because of their ‘preformed’ 3D spatial arrangements, which
provides structural complementarity to different binding site.
As the MoRFs constitute minimal structural motifs, the MoRF-
receptor structural complementarity provides only on a few
protein/peptide specific contacts, resulting in a relatively low
binding enthalpy contribution. For instance, when in complex
with the S100B(bb) dimer, the p53-CTD peptide is in a helical
conformation.23 Within our the minimal MoRF-recognition
framework, the S100B(bb) dimer selects one (or more) of the
single helical turn-containing MoRFs found in the p53-CTD
conformational ensemble to form an initial recognition (or
nucleation) complex. Completion of the folding, with a corres-
ponding increment of the binding affinity, will proceed by induced
fit.26 The completion of the helical motif after binding is in
agreement with the observation that in the absence of stabilizing
tertiary interactions, a-helices rarely persist in isolation,59 and it is
also supported by the instability of the S100B(bb)-bound helical
conformation of the p53-CTD peptide when unbound in solution,
see Table 1.
As shown in Fig. 6, an example of a potential recognition
complex can be built by structural alignment of the backbone
atoms of the 376STS378 helical turn MoRF, the highest populated
helical motif over the cumulative 20 ms, onto the bound peptide
conformation. The structure of the S100B(bb)/p53-CTD NMR
complex23 reveals sets of specific ligand-receptor interactions,
which include a hydrogen bond between Ser 376 of p53-CTD
and Glu 45 of S100B(bb), an salt-bridge between Arg 379 of
p53-CTD and Glu 49 of S100B(bb), and the insertion of Leu 383
into the hydrophobic binding groove. As shown in Fig. 6, these
interactions are conserved in the putative recognition complex
and retained during a 100 ns MD structure relaxation run.
Notably, the disordered character of the unbound N-terminal
tail of the peptide highlighted in the NMR structure23 is also well
reproduced.
Another potential example of MoRF-based conformational
selection can explain the binding of a p53-CTD peptide with
sirtuin Sir2 (PDBid 2h2f).25 The only resolved residues of the
p53-CTD peptide in the complex are the one directly in contact
with the Sir2 binding site, namely 378SRKKLM383. While most of
Fig. 4 Average Rg values (nm), calculated over the 10, 2 ms trajectories, ordered from smaller to larger values. Above each bar are indicated the largest
percentages of secondary structures identified during each trajectory, with (e) indicating b-sheet motifs, (b) b-bridges, (g h1) 310/a helical single turns,
and (t/c) turns and coils.
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the contact between Sir2 and its target peptide involve mostly
backbone atoms,25 as shown in Fig. 7, when in complex with
the unmodified p53-CTD peptide, a few significant specific
contacts can be highlighted. More specifically, Lys 381 of
p53-CTD is in a salt bridge with the Gly 163 backbone carbonyl
of Sir2, while the sidechain of Lys 382, targeted by acetylation,
protrudes into the Sir2 binding site, with Phe 162 and His 116
flanking the aliphatic side chain, and the amino group bound
to a water molecule.25 Based on the structural data available,
the transition from conformational disorder to order upon
binding appears to be less significant in this case relative to
the S100B(bb). Nevertheless, if we consider the interactions
between the Sir2 and Lys 381 and 382 of p53-CTD as potential
recognition contacts, we have 2 examples, shown in Fig. 7,
of potentially recognized MoRFs in coil/turn conformation,
with an optimal orientation of the Lys sidechains for initial
recognition.
To our knowledge there are no structures of complexes with
the unmodified p53-CTD in an asymmetric b-sheet conformation;
nevertheless, we are currently investigating the recognition of the
highest populated p53-CTD MoRF, namely the b-sheet or b-bridge-
containing asymmetric hairpin, by b-sheet structured binding
sites, such as in the PCL1-PHD1 domain.65
Because of their relatively low populations and frequent
interconversion, the p53-CTD peptide structural MoRFs will be
extremely difficult, if not impossible, to characterize experimentally.
Fig. 5 Comparison of the conformational propensity per residue calculated from the 20 ms MD simulations to the disorder prediction tools s2D on panel
(a), and PONDR-VL-XT on panel (b). The legends on the right-hand side of the graphs indicate specific secondary structure motifs, namely b sheets (e),
a (h) and 310 helices (g), b bridges (b), turns (t) and coils (c). Secondary structure assignments have been done with STRIDE.
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Indeed, existing NMR23 and CD60 data show that the p53-CTD
section is highly disordered when unbound in solution. Never-
theless, based on the information discussed in this work,
experimental support for the MoRF-driven molecular recognition
mechanism could be obtained by biasing the conformational
ensemble towards specific structural MoRFs by means, for
example, of stapling the peptide.66 More specifically, based on
the potential recognition discussed earlier in this section of the
376STS378 helical turn by S100B(bb) as the initial, low affinity
recognition complex, a suitably placed aliphatic chain staple
Fig. 6 (Panel a) Close up on specific contacts the helical MoRF p53-CTD peptide (red) makes during the 100 ns MD when in one of the potential
recognition complexes with S100B(bb) (grey). Shown from top to bottom, the hydrogen bond interaction between Ser 376 of p53-CTD and Glu 49 of
S100B(bb), the salt bridge between Arg 379 of p53-CTD and Glu 45 of S100B(bb), and the interaction of Leu 383 inserted in the hydrophobic binding
groove of S100B(bb). (Panel b) Structure of the recognition complex built by structural alignment of a peptide containing the STS helical (red) turn on to
the p53-CTD bound conformation. (Panel c) Set of contacts highlighted in panel (a) shown for the bound conformation of the p53-CTD peptide (green)
in complex with S100B(bb), PDBid 1dt7.
Fig. 7 Potential recognition complexes between the p53-CTD peptide (in purple) and Sir2Tm (in green), PDBid 2h2f, obtained by structural alignment of
MoRFs identified through clustering analysis of 20 ms MD trajectories. In panel (a) alignment of the middle structure from cluster 8 of MD5 (in red) with a
RMSD based on 4 Ca atoms of 0.4 Å, in panel (b) alignment of the middle structure from cluster 8 of MD9 (in cyan) with a RMSD based on 4 Ca atoms of
0.3 Å. Peptide sequence and respective secondary structures assignments (STRIDE) are indicated in the legend.
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would enhance the conformational propensity of the helical
MoRF, thus its population, without affecting sequence integrity.
Changes in relative conformers populations would affect binding
kinetics. Furthermore, the role of MoRFs in p53-CTD recognition
and binding could also be tested by introducing mutations that
suppress specific structural motifs. Indeed, in the case of the
small disordered protein PUMA, an Ala-Gly scanning scheme was
put in place to suppress helicity without affecting residual
structural propensity in solution.30 Binding kinetics showed that
the mutations do not affect k+, suggesting that folding occurs by
an induced fit-driven mechanism.30 As a proof of principle, based
on the recognition mechanism proposed earlier for the 376STS378
310 helical turn MoRF by S100B(bb), mutations of Thr 377 and/or
Ser 378 would affect conformational propensity without com-
promising specific contacts with the receptor. Work in this
direction is currently underway.
Conclusions
In this work we have used extended conformational sampling
through conventional MD simulations to determine the degree
of residual secondary structure within the conformational
disorder at equilibrium of a 22 residue peptide, corresponding
to the 367–388 region of the p53 C-terminal domain (p53-CTD).
This peptide contains all binding determinants of the p53-CTD
within the active p53 tumour suppressor.23,25 Clustering analysis
of the MD trajectories, accounting for a cumulative time of over
20 ms, show the p53-CTD peptide has a high conformational
flexibility, but also a distinct propensity for the formation of
specific and short structural motifs that encompass 3 to 4 residue
at most. Furthermore, a per residue analysis of the conforma-
tional propensity along the p53-CTD peptide shows that these
structural motifs are localized along the sequence, involving
specific groups of residues. Localization of the structural MoRFs
makes the p53-CTD C-terminal half less disordered than the
N-terminal half. This observation is also in agreement with disorder
predictions obtained with the s2D44 and PONDR-VL-XT45 secondary
structure and disorder prediction tools. We propose that the
functional role of these minimal structural molecular recognition
features (MoRFs) is to confer to the p53-CTD binding specificity
towards different receptors, whereby each receptor would have a
higher affinity for a specific MoRF due to 3D structural com-
plementarity, based on a reduced number of contacts, relative to
the final, bound conformation. Molecular recognition through
selection of specific MoRFs, would lead to the completion of
folding through induced fit. This mechanism is consistent with
the molecular recognition proposed for other IDP systems,34
although it does not necessarily preclude access to other recognition
and binding pathways,30,34 that could in principle coexist.
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